AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $293,907 | -34.5% | 24,170 | -32.3% | 0.03% | -38.3% |
| Q2 2023 | $448,693 | +160.1% | 35,724 | +129.6% | 0.05% | +135.0% |
| Q1 2023 | $172,516 | -79.9% | 15,556 | -77.8% | 0.02% | -84.1% |
| Q4 2022 | $857,227 | +69.3% | 70,207 | +44.8% | 0.13% | +147.1% |
| Q3 2022 | $506,330 | +148.2% | 48,499 | +155.0% | 0.05% | +88.9% |
| Q2 2022 | $204,000 | +1.5% | 19,016 | +9.1% | 0.03% | -43.8% |
| Q4 2021 | $201,000 | +27.2% | 17,431 | +6.1% | 0.05% | +20.0% |
| Q2 2021 | $158,000 | -72.9% | 16,435 | -73.5% | 0.04% | -74.4% |
| Q1 2021 | $583,000 | +74.0% | 62,072 | +325.2% | 0.16% | +10.6% |
| Q4 2020 | $335,000 | – | 14,597 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |